Clinical isolation syndrome (CIS) is a disorder of the nervous system with complex clinical outcomes that often involve multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory tests, and pathological activation.
The platform can help align national and international authorities with teams to provide accurate diagnosis and treatment regimens. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many diseases of the nervous system that have previously been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of clinical isolation syndrome CIS. The platform serves a team of authoritative experts at home and abroad in the field of neural systems coupled with the Chinese international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.